tiprankstipranks
TCR2 Therapeutics Inc (TCRR)
NASDAQ:TCRR
Holding TCRR?
Track your performance easily

TCR2 Therapeutics (TCRR) Stock Forecast & Price Target

404 Followers
See the Price Targets and Ratings of:

TCRR Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
TCR2
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TCRR Stock 12 Month Forecast

There Are No Analyst Ratings for TCRR In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

TCRR Financial Forecast

No data currently available

TCRR Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

TCRR Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
EF Hutton
$2
Hold
35.14%
Upside
Reiterated
03/23/23
Analysts Offer Insights on Healthcare Companies: TCR2 Therapeutics (NASDAQ: TCRR) and Inozyme Pharma (NASDAQ: INZY)
Jefferies
$3
Hold
102.70%
Upside
Downgraded
03/09/23
Analysts Offer Insights on Healthcare Companies: TCR2 Therapeutics (NASDAQ: TCRR) and Nurix Therapeutics (NASDAQ: NRIX)
Truist Financial
$3
Hold
102.70%
Upside
Downgraded
03/07/23
TCR2 Therapeutics downgraded to Hold from Buy at TruistTCR2 Therapeutics downgraded to Hold from Buy at Truist
H.C. Wainwright
Hold
Downgraded
03/07/23
TCR2 Therapeutics (TCRR) was downgraded to a Hold Rating at H.C. Wainwright
Piper Sandler
$10
Buy
575.68%
Upside
Reiterated
01/05/23
TCR2 Therapeutics price target raised to $10 from $8 at Piper SandlerTCR2 Therapeutics price target raised to $10 from $8 at Piper Sandler
SVB Securities
$2
Hold
35.14%
Upside
Reiterated
01/05/23
SVB Securities Keeps Their Hold Rating on TCR2 Therapeutics (TCRR)

Best Analysts Covering TCR2 Therapeutics

Which Analyst Should I Follow If I Want to Buy TCRR and Sell After:
1 Month
xxx
Success Rate
4/13 ratings generated profit
31%
Average Return
-5.18%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 30.77% of your transactions generating a profit, with an average return of -5.18% per trade.
3 Months
xxx
Success Rate
3/13 ratings generated profit
23%
Average Return
-10.70%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 23.08% of your transactions generating a profit, with an average return of -10.70% per trade.
1 Year
Do KimPiper Sandler
Success Rate
4/13 ratings generated profit
31%
Average Return
-37.24%
reiterated a buy rating 2 years ago
Copying Do Kim's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade.
2 Years
xxx
Success Rate
3/13 ratings generated profit
23%
Average Return
-47.72%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 23.08% of your transactions generating a profit, with an average return of -47.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TCRR Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

TCRR Stock Forecast FAQ

What is TCRR’s average 12-month price target, according to analysts?
Currently, no data Available
What is TCRR’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TCRR, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TCRR a Buy, Sell or Hold?
      Currently, no data Available
      What is TCR2 Therapeutics Inc’s price target?
      Currently, no data Available
      What do analysts say about TCR2 Therapeutics Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of TCRR?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis